Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
vby-036 (2 trials)
vby-376 (1 trial)
vby-891 (1 trial)
Hepatitis (Phase 1)
Hepatitis C (Phase 1)
Hepatitis C, Chronic (Phase 1)
Trials (4 total)
Trial APIs (3 total)